Mongolia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National

Download

Value (%)	Year	Type	Source
4.28 (3.88 - 4.70)	2019	Modelled	IHME
4.44 (4.02 - 4.86)	2018	Modelled	IHME
4.55 (4.08 - 5.03)	2017	Modelled	IHME
4.6 (4.12 - 5.03)	2016	Modelled	IHME
4.65 (4.14 - 5.15)	2015	Modelled	IHME
4.75 (4.22 - 5.24)	2014	Modelled	IHME
4.9 (4.34 - 5.38)	2013	Modelled	IHME
5.07 (4.47 - 5.56)	2012	Modelled	IHME
5.22 (4.60 - 5.75)	2011	Modelled	IHME
5.34 (4.67 - 5.89)	2010	Modelled	IHME
5.42 (4.75 - 5.99)	2009	Modelled	IHME
5.48 (4.81 - 6.05)	2008	Modelled	IHME
5.54 (4.85 - 6.11)	2007	Modelled	IHME
5.59 (4.88 - 6.20)	2006	Modelled	IHME
5.65 (4.88 - 6.31)	2005	Modelled	IHME
5.72 (4.95 - 6.40)	2004	Modelled	IHME
5.78 (4.98 - 6.49)	2003	Modelled	IHME
5.85 (4.98 - 6.57)	2002	Modelled	IHME
5.92 (5 - 6.69)	2001	Modelled	IHME
6.01 (5.01 - 6.83)	2000	Modelled	IHME
6.13 (5.11 - 6.95)	1999	Modelled	IHME
6.3 (5.28 - 7.14)	1998	Modelled	IHME
6.48 (5.48 - 7.32)	1997	Modelled	IHME
6.63 (5.65 - 7.51)	1996	Modelled	IHME
6.73 (5.70 - 7.68)	1995	Modelled	IHME
6.78 (5.71 - 7.73)	1994	Modelled	IHME
6.83 (5.72 - 7.81)	1993	Modelled	IHME
6.87 (5.72 - 7.90)	1992	Modelled	IHME
6.9 (5.71 - 7.99)	1991	Modelled	IHME
6.91 (5.70 - 8.12)	1990	Modelled	IHME
10.8 (8.80 - 13.31)	2015	Modelled	WHO
4.1 (3.10 - 4.80)	2016	Modelled	Razavi-Shearer et al, 2018

Showing out of

Children under-5 years

Download

Value (%)	Year	Type	Source
0.29 (0.20 - 0.36)	2019	Modelled	IHME
0.31 (0.21 - 0.41)	2018	Modelled	IHME
0.33 (0.22 - 0.43)	2017	Modelled	IHME
0.32 (0.22 - 0.42)	2016	Modelled	IHME
0.31 (0.21 - 0.40)	2015	Modelled	IHME
0.33 (0.22 - 0.42)	2014	Modelled	IHME
0.35 (0.24 - 0.46)	2013	Modelled	IHME
0.4 (0.27 - 0.51)	2012	Modelled	IHME
0.44 (0.29 - 0.58)	2011	Modelled	IHME
0.49 (0.32 - 0.64)	2010	Modelled	IHME
0.56 (0.36 - 0.73)	2009	Modelled	IHME
0.64 (0.43 - 0.84)	2008	Modelled	IHME
0.73 (0.49 - 0.95)	2007	Modelled	IHME
0.8 (0.53 - 1.03)	2006	Modelled	IHME
0.82 (0.55 - 1.07)	2005	Modelled	IHME
0.82 (0.54 - 1.07)	2004	Modelled	IHME
0.81 (0.52 - 1.07)	2003	Modelled	IHME
0.79 (0.50 - 1.06)	2002	Modelled	IHME
0.78 (0.48 - 1.06)	2001	Modelled	IHME
0.78 (0.47 - 1.06)	2000	Modelled	IHME
0.79 (0.49 - 1.08)	1999	Modelled	IHME
0.84 (0.53 - 1.12)	1998	Modelled	IHME
0.9 (0.59 - 1.19)	1997	Modelled	IHME
0.99 (0.66 - 1.29)	1996	Modelled	IHME
1.09 (0.75 - 1.41)	1995	Modelled	IHME
1.29 (0.90 - 1.66)	1994	Modelled	IHME
1.65 (1.13 - 2.14)	1993	Modelled	IHME
2.12 (1.42 - 2.80)	1992	Modelled	IHME
2.69 (1.78 - 3.60)	1991	Modelled	IHME
3.3 (2.18 - 4.48)	1990	Modelled	IHME
1.72 (1.14 - 2.57)	2015	Modelled	WHO
0.5 (0.40 - 0.70)	2009	Survey/reported	WHO WPRO, Woodring J et al, 2017

Showing out of

Technical notes

Number of people living with chronic HBV

National

Download

Value	Year	Type	Source
148,908 (122,697 - 174,814)	1990	Modelled	IHME
151,393 (125,232 - 175,361)	1991	Modelled	IHME
153,322 (127,492 - 176,219)	1992	Modelled	IHME
154,715 (129,534 - 176,726)	1993	Modelled	IHME
155,680 (130,998 - 177,450)	1994	Modelled	IHME
156,324 (132,363 - 178,509)	1995	Modelled	IHME
155,852 (132,825 - 176,369)	1996	Modelled	IHME
153,876 (130,154 - 173,816)	1997	Modelled	IHME
151,235 (126,788 - 171,420)	1998	Modelled	IHME
148,710 (123,797 - 168,464)	1999	Modelled	IHME
147,203 (122,714 - 167,206)	2000	Modelled	IHME
146,601 (123,643 - 165,447)	2001	Modelled	IHME
146,322 (124,667 - 164,400)	2002	Modelled	IHME
146,288 (125,961 - 164,251)	2003	Modelled	IHME
146,470 (126,686 - 163,971)	2004	Modelled	IHME
146,787 (126,822 - 163,832)	2005	Modelled	IHME
147,363 (128,487 - 163,415)	2006	Modelled	IHME
148,250 (129,792 - 163,701)	2007	Modelled	IHME
149,313 (131,019 - 164,762)	2008	Modelled	IHME
150,343 (131,775 - 166,211)	2009	Modelled	IHME
151,141 (132,299 - 166,854)	2010	Modelled	IHME
150,896 (132,927 - 166,063)	2011	Modelled	IHME
149,482 (132,020 - 163,975)	2012	Modelled	IHME
147,659 (130,730 - 162,300)	2013	Modelled	IHME
146,270 (129,864 - 161,378)	2014	Modelled	IHME
146,212 (130,031 - 161,961)	2015	Modelled	IHME
147,679 (132,234 - 161,446)	2016	Modelled	IHME
148,920 (133,519 - 164,690)	2017	Modelled	IHME
148,043 (133,909 - 161,766)	2018	Modelled	IHME
145,106 (131,459 - 159,109)	2019	Modelled	IHME
126,000 (95,000 - 146,000)	2016	Modelled	Razavi-Shearer et al, 2018

Showing out of

HBV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
29.1 (20.30 - 39.90)	2019	Modelled	IHME
29.1 (20.50 - 40)	2018	Modelled	IHME
29 (20.60 - 39.80)	2017	Modelled	IHME
28.6 (20.40 - 38.90)	2016	Modelled	IHME
28 (20.20 - 38.10)	2015	Modelled	IHME
27.9 (20.20 - 37.30)	2014	Modelled	IHME
27.9 (20.60 - 36.90)	2013	Modelled	IHME
28 (20.90 - 36.40)	2012	Modelled	IHME
28.1 (21 - 36.20)	2011	Modelled	IHME
28 (21 - 36.10)	2010	Modelled	IHME
27.5 (20.60 - 35.20)	2009	Modelled	IHME
26.8 (20.30 - 34.30)	2008	Modelled	IHME
26.3 (19.90 - 33.40)	2007	Modelled	IHME
25.8 (19.70 - 32.90)	2006	Modelled	IHME
25.2 (19.20 - 32.40)	2005	Modelled	IHME
24.8 (19 - 31.60)	2004	Modelled	IHME
24.7 (18.90 - 31.70)	2003	Modelled	IHME
24.6 (19 - 31.50)	2002	Modelled	IHME
24.5 (18.90 - 31.40)	2001	Modelled	IHME
24 (18.60 - 30.40)	2000	Modelled	IHME
23.7 (18.40 - 29.70)	1999	Modelled	IHME
23.8 (18.60 - 29.70)	1998	Modelled	IHME
24 (18.90 - 30.10)	1997	Modelled	IHME
24.3 (19.30 - 30.40)	1996	Modelled	IHME
24.2 (19.20 - 30.40)	1995	Modelled	IHME
24.1 (19 - 30)	1994	Modelled	IHME
24.2 (19.10 - 30.10)	1993	Modelled	IHME
24 (19 - 29.80)	1992	Modelled	IHME
24 (19 - 29.90)	1991	Modelled	IHME
23.9 (18.70 - 30)	1990	Modelled	IHME

Showing out of

Technical notes

HBV-related deaths

National

Download

Value	Year	Type	Source
987 (689 - 1,351)	2019	Modelled	IHME
970 (682 - 1,333)	2018	Modelled	IHME
948 (672 - 1,301)	2017	Modelled	IHME
917 (655 - 1,249)	2016	Modelled	IHME
882 (636 - 1,199)	2015	Modelled	IHME
859 (621 - 1,148)	2014	Modelled	IHME
841 (620 - 1,113)	2013	Modelled	IHME
826 (617 - 1,075)	2012	Modelled	IHME
813 (607 - 1,046)	2011	Modelled	IHME
794 (593 - 1,022)	2010	Modelled	IHME
762 (572 - 977)	2009	Modelled	IHME
729 (552 - 934)	2008	Modelled	IHME
704 (534 - 895)	2007	Modelled	IHME
680 (520 - 866)	2006	Modelled	IHME
654 (500 - 841)	2005	Modelled	IHME
635 (488 - 810)	2004	Modelled	IHME
625 (479 - 802)	2003	Modelled	IHME
616 (476 - 789)	2002	Modelled	IHME
607 (468 - 778)	2001	Modelled	IHME
587 (456 - 745)	2000	Modelled	IHME
574 (445 - 721)	1999	Modelled	IHME
571 (447 - 713)	1998	Modelled	IHME
571 (450 - 716)	1997	Modelled	IHME
572 (453 - 715)	1996	Modelled	IHME
563 (445 - 707)	1995	Modelled	IHME
552 (437 - 688)	1994	Modelled	IHME
547 (432 - 681)	1993	Modelled	IHME
536 (423 - 665)	1992	Modelled	IHME
527 (418 - 656)	1991	Modelled	IHME
515 (403 - 647)	1990	Modelled	IHME
1,363	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HBV

National

Download

Value (%)	Year	Type	Source
30 (22 - 39)	2019	Modelled	IHME
30 (23 - 40)	2018	Modelled	IHME
30 (23 - 39)	2017	Modelled	IHME
30 (23 - 39)	2016	Modelled	IHME
30 (23 - 39)	2015	Modelled	IHME
31 (23 - 39)	2014	Modelled	IHME
31 (23 - 39)	2013	Modelled	IHME
31 (23 - 39)	2012	Modelled	IHME
31 (24 - 39)	2011	Modelled	IHME
31 (24 - 39)	2010	Modelled	IHME
31 (24 - 39)	2009	Modelled	IHME
31 (24 - 40)	2008	Modelled	IHME
31 (24 - 40)	2007	Modelled	IHME
31 (24 - 40)	2006	Modelled	IHME
32 (24 - 40)	2005	Modelled	IHME
32 (24 - 41)	2004	Modelled	IHME
33 (25 - 42)	2003	Modelled	IHME
33 (25 - 43)	2002	Modelled	IHME
34 (26 - 44)	2001	Modelled	IHME
35 (26 - 44)	2000	Modelled	IHME
35 (27 - 45)	1999	Modelled	IHME
35 (27 - 45)	1998	Modelled	IHME
35 (27 - 45)	1997	Modelled	IHME
35 (27 - 45)	1996	Modelled	IHME
35 (27 - 45)	1995	Modelled	IHME
35 (27 - 45)	1994	Modelled	IHME
35 (27 - 45)	1993	Modelled	IHME
35 (26 - 44)	1992	Modelled	IHME
34 (26 - 44)	1991	Modelled	IHME
34 (25 - 44)	1990	Modelled	IHME

Showing out of

Technical notes

Coverage of HepB birth dose

Newborns

Download

Value (%)	Year	Type	Source
98	2018	Survey/reported	WHO/UNICEF
98	2017	Survey/reported	WHO/UNICEF
98	2016	Survey/reported	WHO/UNICEF
97	2015	Survey/reported	WHO/UNICEF
97	2014	Survey/reported	WHO/UNICEF
97	2013	Survey/reported	WHO/UNICEF
97	2012	Survey/reported	WHO/UNICEF
96	2011	Survey/reported	WHO/UNICEF
95	2010	Survey/reported	WHO/UNICEF
98	2009	Survey/reported	WHO/UNICEF
94	2008	Survey/reported	WHO/UNICEF
97	2007	Survey/reported	WHO/UNICEF
98	2006	Survey/reported	WHO/UNICEF
89	2005	Survey/reported	WHO/UNICEF
98	2004	Survey/reported	WHO/UNICEF
99	2003	Survey/reported	WHO/UNICEF
98	2002	Survey/reported	WHO/UNICEF
98	2001	Survey/reported	WHO/UNICEF
96	2000	Survey/reported	WHO/UNICEF
98	2019	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants

Download

Value (%)	Year	Type	Source
99	2018	Survey/reported	WHO/UNICEF
99	2017	Survey/reported	WHO/UNICEF
99	2016	Survey/reported	WHO/UNICEF
99	2015	Survey/reported	WHO/UNICEF
99	2014	Survey/reported	WHO/UNICEF
98	2013	Survey/reported	WHO/UNICEF
99	2012	Survey/reported	WHO/UNICEF
99	2011	Survey/reported	WHO/UNICEF
96	2010	Survey/reported	WHO/UNICEF
97	2009	Survey/reported	WHO/UNICEF
96	2008	Survey/reported	WHO/UNICEF
98	2007	Survey/reported	WHO/UNICEF
98	2006	Survey/reported	WHO/UNICEF
98	2005	Survey/reported	WHO/UNICEF
98	2004	Survey/reported	WHO/UNICEF
98	2003	Survey/reported	WHO/UNICEF
98	2002	Survey/reported	WHO/UNICEF
95	2001	Survey/reported	WHO/UNICEF
93	2000	Survey/reported	WHO/UNICEF
92	1999	Survey/reported	WHO/UNICEF
91	1998	Survey/reported	WHO/UNICEF
88	1997	Survey/reported	WHO/UNICEF
93	1996	Survey/reported	WHO/UNICEF
88	1995	Survey/reported	WHO/UNICEF
67	1994	Survey/reported	WHO/UNICEF
69	1993	Survey/reported	WHO/UNICEF
47	1992	Survey/reported	WHO/UNICEF
18	1991	Survey/reported	WHO/UNICEF
98	2019	Survey/reported	WHO/UNICEF

Showing out of

Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)

Download

Value (%)	Year	Type	Source
0	2016	Survey/reported	Harm Reduction International, 2016

HBV National Action Plan

HBV elimination goal

Source:

Year of HBV elimination goal

2030

Source:

HepB birth dose policy

Yes

Source: WHO

Year of birth dose introduction

2002

Source: WHO

Eligible for HBV generic medicines

Source: MPP

HCV National Action Plan

HCV elimination goal

Source:

Year of HCV elimination goal

2020

Source:

Eligible for HCV generic medicines

Source: MPP

At least one needle-syringe exchange program (NSP) operational

Yes

Source: Harm Reduction International

At least one opioid substitution therapy (OST) program operational

Source: Harm Reduction International

NSP in at least one prison

Source: Harm Reduction International

OST in at least one prison

Source: Harm Reduction International

% of substance use disorder facilities offering hepatitis testing

Some (11-30%)

Source: WHO

% of substance use disorder facilities offering hepatitis treatment

Some (11-30%)

Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National

Download

Value (%)	Year	Type	Source
9.34 (7.16 - 12.08)	2019	Modelled	IHME
9.4 (7.25 - 12.30)	2018	Modelled	IHME
9.49 (7.26 - 12.61)	2017	Modelled	IHME
9.67 (7.43 - 12.78)	2016	Modelled	IHME
9.88 (7.34 - 13.19)	2015	Modelled	IHME
10.11 (7.57 - 13.37)	2014	Modelled	IHME
10.4 (7.81 - 13.61)	2013	Modelled	IHME
10.67 (8.11 - 13.80)	2012	Modelled	IHME
10.88 (8.28 - 13.95)	2011	Modelled	IHME
10.96 (8.33 - 14.12)	2010	Modelled	IHME
10.84 (8.26 - 13.85)	2009	Modelled	IHME
10.53 (8.07 - 13.33)	2008	Modelled	IHME
10.15 (7.82 - 12.71)	2007	Modelled	IHME
9.79 (7.55 - 12.20)	2006	Modelled	IHME
9.58 (7.39 - 11.97)	2005	Modelled	IHME
9.47 (7.42 - 11.73)	2004	Modelled	IHME
9.37 (7.41 - 11.49)	2003	Modelled	IHME
9.29 (7.34 - 11.41)	2002	Modelled	IHME
9.23 (7.37 - 11.33)	2001	Modelled	IHME
9.21 (7.35 - 11.34)	2000	Modelled	IHME
9.2 (7.37 - 11.33)	1999	Modelled	IHME
9.2 (7.40 - 11.39)	1998	Modelled	IHME
9.2 (7.39 - 11.43)	1997	Modelled	IHME
9.2 (7.37 - 11.47)	1996	Modelled	IHME
9.2 (7.31 - 11.50)	1995	Modelled	IHME
9.19 (7.33 - 11.51)	1994	Modelled	IHME
9.18 (7.35 - 11.50)	1993	Modelled	IHME
9.16 (7.29 - 11.45)	1992	Modelled	IHME
9.15 (7.29 - 11.41)	1991	Modelled	IHME
9.13 (7.26 - 11.42)	1990	Modelled	IHME
6.4 (4.30 - 7.90)	2015	Modelled	Blach et al, 2017
7.5 (6.10 - 10.90)	2014	Survey/reported	Gower et al, 2014

Showing out of

Women of childbearing age (15–49 years)

Download

Value (%)	Year	Type	Source
5.14 (3.46 - 6.28)	2019	Modelled	Dugan et al., 2021

Technical notes

Prevalence of anti-HCV

National

Download

Value (%)	Year	Type	Source
10.8 (8.70 - 15.60)	2014	Survey/reported	Gower et al, 2014
10.8 (8.70 - 15.60)	2014	Survey/reported	Gower et al, 2014
9.8	2019	Modelled	Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis

Showing out of

Men who have sex with men (MSM)

Download

Value (%)	Year	Type	Source
18	2019	Modelled	Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis

Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National

Download

Value	Year	Type	Source
196,661 (156,414 - 245,865)	1990	Modelled	IHME
200,685 (159,803 - 250,179)	1991	Modelled	IHME
204,428 (162,520 - 255,461)	1992	Modelled	IHME
207,814 (166,437 - 260,338)	1993	Modelled	IHME
210,869 (168,275 - 264,095)	1994	Modelled	IHME
213,617 (169,862 - 267,144)	1995	Modelled	IHME
216,132 (173,090 - 269,592)	1996	Modelled	IHME
218,484 (175,426 - 271,354)	1997	Modelled	IHME
220,812 (177,491 - 273,248)	1998	Modelled	IHME
223,127 (178,578 - 274,794)	1999	Modelled	IHME
225,571 (180,087 - 277,675)	2000	Modelled	IHME
228,496 (182,346 - 280,505)	2001	Modelled	IHME
232,367 (183,587 - 285,389)	2002	Modelled	IHME
237,054 (187,579 - 290,784)	2003	Modelled	IHME
242,512 (189,975 - 300,447)	2004	Modelled	IHME
248,611 (191,782 - 310,738)	2005	Modelled	IHME
257,987 (198,837 - 321,473)	2006	Modelled	IHME
271,610 (209,275 - 340,291)	2007	Modelled	IHME
286,861 (219,913 - 363,083)	2008	Modelled	IHME
300,823 (229,337 - 384,374)	2009	Modelled	IHME
310,393 (235,739 - 399,832)	2010	Modelled	IHME
314,389 (239,350 - 402,943)	2011	Modelled	IHME
314,890 (239,291 - 407,295)	2012	Modelled	IHME
313,349 (235,286 - 410,093)	2013	Modelled	IHME
311,386 (233,147 - 411,857)	2014	Modelled	IHME
310,716 (230,860 - 414,882)	2015	Modelled	IHME
310,171 (238,318 - 410,167)	2016	Modelled	IHME
310,523 (237,505 - 412,587)	2017	Modelled	IHME
313,093 (241,351 - 409,580)	2018	Modelled	IHME
316,502 (242,400 - 409,223)	2019	Modelled	IHME
194,000 (131,000 - 237,000)	2015	Modelled	Blach et al, 2017

Showing out of

Women of childbearing age (15–49 years)

Download

Value	Year	Type	Source
43,800 (29,400 - 53,500)	2019	Modelled	Dugan et al., 2021

HCV-related death rate

National

Download

Value (per 100,000)	Year	Type	Source
30.8 (22.50 - 41)	2019	Modelled	IHME
30.2 (22.20 - 39.80)	2018	Modelled	IHME
29.7 (21.90 - 39.30)	2017	Modelled	IHME
29.5 (21.70 - 39.20)	2016	Modelled	IHME
28.8 (21.50 - 38.20)	2015	Modelled	IHME
28.7 (21.80 - 37.70)	2014	Modelled	IHME
28.8 (21.90 - 37.60)	2013	Modelled	IHME
29 (22 - 37.60)	2012	Modelled	IHME
29.4 (22.10 - 37.90)	2011	Modelled	IHME
29.3 (22.20 - 37.50)	2010	Modelled	IHME
28.7 (21.90 - 36.50)	2009	Modelled	IHME
28 (21.30 - 35.50)	2008	Modelled	IHME
27.5 (21.10 - 34.70)	2007	Modelled	IHME
26.9 (20.50 - 34.30)	2006	Modelled	IHME
25.9 (19.60 - 33.20)	2005	Modelled	IHME
24.7 (18.80 - 31.70)	2004	Modelled	IHME
23.4 (17.70 - 30.10)	2003	Modelled	IHME
21.8 (16.30 - 28.30)	2002	Modelled	IHME
20.4 (15.20 - 26.80)	2001	Modelled	IHME
18.9 (14 - 24.70)	2000	Modelled	IHME
17.9 (13.30 - 23.50)	1999	Modelled	IHME
17.4 (13 - 22.70)	1998	Modelled	IHME
17.1 (13 - 22.40)	1997	Modelled	IHME
17.1 (13 - 22.50)	1996	Modelled	IHME
16.9 (12.80 - 22)	1995	Modelled	IHME
16.7 (12.80 - 21.60)	1994	Modelled	IHME
16.9 (12.90 - 21.90)	1993	Modelled	IHME
17.1 (13.20 - 21.90)	1992	Modelled	IHME
17.3 (13.30 - 22.10)	1991	Modelled	IHME
17.4 (13.10 - 22.20)	1990	Modelled	IHME

Showing out of

Technical notes

HCV-related deaths

National

Download

Value	Year	Type	Source
1,044 (763 - 1,389)	2019	Modelled	IHME
1,005 (740 - 1,326)	2018	Modelled	IHME
973 (715 - 1,284)	2017	Modelled	IHME
945 (698 - 1,258)	2016	Modelled	IHME
905 (677 - 1,202)	2015	Modelled	IHME
882 (670 - 1,161)	2014	Modelled	IHME
870 (660 - 1,133)	2013	Modelled	IHME
857 (649 - 1,110)	2012	Modelled	IHME
848 (638 - 1,094)	2011	Modelled	IHME
830 (627 - 1,061)	2010	Modelled	IHME
796 (607 - 1,013)	2009	Modelled	IHME
762 (580 - 968)	2008	Modelled	IHME
735 (566 - 929)	2007	Modelled	IHME
710 (540 - 903)	2006	Modelled	IHME
674 (510 - 862)	2005	Modelled	IHME
634 (481 - 811)	2004	Modelled	IHME
593 (449 - 762)	2003	Modelled	IHME
547 (407 - 708)	2002	Modelled	IHME
505 (376 - 664)	2001	Modelled	IHME
462 (343 - 605)	2000	Modelled	IHME
433 (323 - 569)	1999	Modelled	IHME
417 (313 - 546)	1998	Modelled	IHME
407 (308 - 532)	1997	Modelled	IHME
402 (304 - 528)	1996	Modelled	IHME
392 (298 - 511)	1995	Modelled	IHME
384 (293 - 496)	1994	Modelled	IHME
382 (292 - 495)	1993	Modelled	IHME
380 (293 - 488)	1992	Modelled	IHME
379 (291 - 485)	1991	Modelled	IHME
374 (283 - 477)	1990	Modelled	IHME
603	2016	Modelled	WHO

Showing out of

Technical notes

Percent of liver cancer deaths attributable to HCV

National

Download

Value (%)	Year	Type	Source
30 (21 - 38)	2019	Modelled	IHME
30 (21 - 38)	2018	Modelled	IHME
30 (21 - 38)	2017	Modelled	IHME
30 (22 - 38)	2016	Modelled	IHME
30 (22 - 38)	2015	Modelled	IHME
30 (22 - 38)	2014	Modelled	IHME
30 (22 - 39)	2013	Modelled	IHME
30 (22 - 39)	2012	Modelled	IHME
31 (23 - 39)	2011	Modelled	IHME
31 (23 - 39)	2010	Modelled	IHME
31 (23 - 39)	2009	Modelled	IHME
31 (23 - 40)	2008	Modelled	IHME
31 (23 - 40)	2007	Modelled	IHME
31 (23 - 40)	2006	Modelled	IHME
31 (23 - 40)	2005	Modelled	IHME
31 (23 - 40)	2004	Modelled	IHME
31 (22 - 40)	2003	Modelled	IHME
30 (22 - 39)	2002	Modelled	IHME
30 (22 - 39)	2001	Modelled	IHME
30 (21 - 38)	2000	Modelled	IHME
29 (21 - 38)	1999	Modelled	IHME
29 (21 - 38)	1998	Modelled	IHME
29 (21 - 38)	1997	Modelled	IHME
29 (21 - 38)	1996	Modelled	IHME
29 (21 - 39)	1995	Modelled	IHME
30 (21 - 39)	1994	Modelled	IHME
30 (21 - 39)	1993	Modelled	IHME
30 (22 - 40)	1992	Modelled	IHME
31 (22 - 40)	1991	Modelled	IHME
31 (22 - 41)	1990	Modelled	IHME